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TO THE EDITOR
The adult human skin is a highly active
immunological organ containing con-
siderable numbers of T cells (Clark
et al., 2006), which are fundamental
for the maintenance of barrier integrity
and immune surveillance (Kupper
and Fuhlbrigge, 2004). The great
majority of resident T cells exhibit a
memory/effector phenotype and express
the skin-homing marker cutaneous
lymphocyte associated antigen (CLA;
Clark et al., 2006) and several
chemokine receptors (CCR4, CCR6,
CCR8, and CCR10; Campbell et al.,
1999; Homey et al., 2002; Schaerli
et al., 2004; McCully et al., 2012).
The CCR10 ligand CCL27/CTACK
(cutaneous T-cell-attracting chemokine)
is specifically expressed by epidermal
keratinocytes (KCs), and its over-
production is associated with an
enhanced influx of CCR10þCD4þ
T cells into the skin in patients with
inflammatory skin diseases such as
atopic or allergic contact dermatitis
and psoriasis (Homey et al., 2002).
This suggests a distinct role for CCR10
in controlling effector T–cell migration
under specific inflammatory conditions
(Reiss et al., 2001; Homey et al., 2002;
Sigmundsdottir et al., 2007) as opposed
to the recently proposed homeostatic
immune surveillance T-cell trafficking
(McCully et al., 2012). Recently,
Di Nuzzo et al. (2009) reported that,
in contrast to adult skin, fetal human
skin harbors mainly naive CLACD4þ
T cells and less CLAþ T cells.
Confirming and extending this work,
we have shown that only low numbers
of CD3þ T cells (up to 20 times lower
as compared with adult skin) were
present in the skin during midgestation
and only rare T cells during the first
trimester, which were exclusively
located in the dermal compartment
(Schuster et al., 2012). After birth,
memory T cells can be readily
identified in the dermis and in the
epidermis and their number increases
with age (Akgu¨n et al., 2012). As it is
unclear which factors/chemokines
control T-cell immigration into the skin
during ontogeny, we investigated in this
study whether the scarcity of T cells in
prenatal human skin correlates with
CCL27 levels produced by epidermal
KCs. To this purpose, we analyzed its
expression and regulation in prenatal
and adult human KCs in monolayer
and in organotypic skin cultures in vitro.
In line with a previous publication
(Homey et al., 2002), we detected
strong CCL27 expression in adult
epidermis preferentially in basal KCs
and the stratum corneum (Figure 1c,
inset). The specificity of the epidermal
staining was confirmed by blocking
experiments using recombinant CCL27
for pre-absorption of the antibody
(Supplementary Figure S1 online).
CCL27 staining of dermal cells, how-
ever, was not inhibited providing further
evidence for an indirect CCL27 reactiv-
ity of dermal cells via the binding of
CCL27 to its receptor CCR10 as sug-
gested previously (Homey et al., 2002).
In contrast, epidermal CCL27 was
virtually absent in embryonic skin
(12 weeks estimated gestational age
(EGA) (Figure 1a) and was marginally
positive in fetal skin (24 weeks EGA),
showing strongest expression in the
uppermost layer (Figure 1b), indicating
a differentiation-dependent regulation of
CCL27 in KCs. To compare the CCL27
secretory potential of fetal and adult
KCs, we cultured primary KCs for
24 hours in the absence or presence of
the toll-like receptor-3 ligand poly(I:C),
a potent inducer of a variety of chemo-
kines including CCL27 (Lebre et al.,
2007). We found that CCL27 mRNA
was comparably expressed in both,
unstimulated fetal and adult KCs
(Figure 1d, Ct-value¼29), whereas
release of CCL27 protein was detectable
only in adult KCs (Figure 1e). Poly (I:C)
induced a strong increase in CCL27
expression and secretion in adult KCs
and a moderate, although significant,
increase in fetal KCs (Figure 1d and e).
When analyzing lysates of fetal and
adult KCs, we found a significant intra-
cellular expression level of CCL27 not
only in KCs from adult but also from
those of fetal donors (Figure 2c). The
striking differences in the CCL27 stain-
ing pattern between prenatal and adult
skin together with the fact that the
prenatal epidermis is not fully differen-
tiated yet (Dale et al., 1985) promptedAccepted article preview online 13 September 2013; published online 17 October 2013
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us to further investigate the effect of
KC differentiation on CCL27 produc-
tion and secretion in vitro. As shown
in Figure 2, CCL27 mRNA (Figure 2a)
and release of CCL27 protein (Figure 2b)
were strongly increased in differentiated
adult KCs. In contrast, induction of
differentiation in fetal KCs failed to
enhance CCL27 production and release
(Figure 2a–c). Analysis of the differentia-
tion-associated proteins loricrin and ker-
atin 10 (Supplementary Figure S2a and b
online) revealed that in KCs of both age
groups, markers of late KC differentia-
tion were readily induced, although
expression levels were lower in fetal
cells. Although our results suggest that
differentiation of KCs may influence
CCL27 release, our assumption needs
to be supported by detailed biochemical
analyses. In contrast to fetal KCs in
monolayer cultures in vitro (Figure 2a–
c), CCL27 expression was distinctly
present in the upper layers of fetal
epidermis (Figure 1b), suggesting that
in vivo additional factors might be pre-
sent and necessary for CCL27 upregula-
tion. These findings extend our previous
work, which showed that CCL27 is not
released by cultured fetal skin single-
cell suspensions either (Schuster et al.,
2012). Furthermore, our observation
that differentiation strongly increases
CCL27 release by adult KCs in vitro
(Figure 2), whereas suprabasal KCs in
adult skin (Figure 1c) show a weaker
staining intensity compared with basal
KCs and the stratum corneum, might
indicate that also in vivo suprabasal,
i.e., differentiated KCs strongly release
CCL27 resulting in a weaker cell–
associated immune reactivity.
To further elaborate the differentia-
tion-dependent expression of CCL27 in
adult KCs, we used an organotypic skin
model, recently established in our
laboratory (Mildner et al., 2010). This
skin model resembles normal human
skin and can be investigated at
different time points of epidermal
differentiation. After 1 day, the epider-
mis is already multilayered but no stra-
tum corneum is present and after 5 days
the model shows all hallmarks of a fully
differentiated epidermis including a
stratum corneum (Figure 2d and e).
High levels of CCL27 expression were
found in all epidermal layers already at
the early time point (Figure 2d and f).
However, as this model reflects epider-
mal regeneration (such as in wound
healing) rather than epidermal develop-
ment during ontogeny, our data suggest
that an enhanced CCL27 release may
have a role in regenerating epidermis.
Indeed, the CCL27/CCR10 axis has been
implicated to be important for epider-
mal wound healing (Inokuma et al.,
2006). The late differentiated organo-
typic skin showed a strong CCL27
expression (Figure 2e and f) and a
staining pattern comparable to that of
adult human skin (Figure 1c).
In summary, we show that adult but
not prenatal human KCs produce and
release large amounts of the T-cell che-
moattractant CCL27. Moreover, we
demonstrate that epidermal CCL27
secretion is strongly dependent on KC
differentiation. Our data further imply
that the triggers responsible for CCL27
expression differ between epidermal
regeneration of postnatal skin and epi-
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Figure 1. Regulation of CCL27 expression in KCs during skin development. Immunofluorescence of cryostat sections from embryonic (a), fetal (b),
and adult (c) skin samples (n¼5) revealed no-to-modest CCL27 positivity in embryonic skin and a strong staining intensity of the outermost epidermal
layer in fetal skin, whereas in adult epidermis both the basal and the cornified layers displayed strong staining (D, dermis; E, epidermis; red: CCL27
staining, blue: nuclei staining; scale bars¼ 40mm). (d) Relative CCL27 mRNA expression of fetal and adult KCs in vitro is shown (n¼ 5). Quantitative reverse
transcription-PCR revealed similar mRNA levels in untreated fetal and adult KCs. Poly (I:C) induced a significantly higher CCL27 mRNA expression in adult
KCs as compared with fetal KCs. (e) CCL27 ELISA of supernatants from fetal and adult KCs is shown (n¼ 5). In contrast to fetal KCs, a low baseline CCL27 secretion
was observed in adult KCs. Poly (I:C) induced a strong upregulation of CCL27 secretion in adult but not in fetal KCs. Each value represents one independent
donor performed in triplicate. Bars represent the mean±SEM of all donors. **Po0.005, ***Po0.0005. KC, keratinocyte.
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Thus, changes in the KC differentiation
process as well as the microenvironment
after birth seem to favor a gradient for
the influx of T cells suggesting a role for
the CCL27/CCR10 chemokine system in
the control of immigrating cutaneous
T cells in the developing human skin.
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Figure 2. CCL27 expression and secretion are regulated during KC differentiation. (a) CCL27 mRNA expression in proliferating (Prol) and differentiated
(Diff) fetal and adult KCs in vitro is shown (n¼5–6). Whereas KC differentiation led to an upregulation of CCL27 mRNA expression in adult KCs, no regulation
was observed in fetal KCs. Analysis of secreted (b) and intracellular (c) CCL27 by ELISA showed an enhanced secretion in adult but not in fetal KCs (n¼3).
(d and e) Organotypic skin either at an early- or a late-differentiation state (n¼ 3) is shown. H&E staining displayed a multilayered but not cornified epithelium
in the early-differentiated sample (d, upper panel) and a fully differentiated epidermis also showing a cornified layer in the late-differentiated sample
(e, upper panel). Immunofluorescence of cryostat sections from organotypic skin revealed a strong staining already in all layers of the early-differentiated sample
(d, lower panel) and a staining pattern similar to adult human skin in the late-differentiated sample (e, lower panel; red: CCL27 staining, blue: nuclei staining,
scale bars¼ 40mm). (f) CCL27 ELISA of secreted CCL27 from organotypic skin cultures is shown (n¼ 3 for each group). Each value represents one independent
donor, each done in triplicate. Bars represent the mean±SEM of all donors. *Po0.05, **Po0.005, ***Po0.0005. H&E, hematoxylin and eosin; KC, keratinocyte.
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TO THE EDITOR
Autosomal recessive congenital ichthyo-
sis (ARCI) is a Mendelian disorder of
keratinization. LI patients are born as
erythrodermic ‘‘collodion’’ babies but
soon become covered with scales. The
most commonly mutated genes in ARCI
are Transglutaminase 1, Ichthyin, and
the Arachidonate Lipoxygenases 12b
and 3 (Russell et al., 1995; Jobard
et al., 2002; Fischer, 2009). Hyper-
keratosis (scaling) is a cardinal feature
of disorders of keratinization, which are
characterized by abnormal barrier
function. For example, Tgm1-null mice
die perinatally because of transepi-
dermal water loss after birth, but
when this skin is grafted onto nude
mice, they form scales similar to ARCI
patients (Kuramoto et al., 2002). The
epidermis is hyperproliferative, pro-
duces increased non-polar lipid, and
the cornified layer is thickened. This
scaling is the principle phenotype in
ARCI patients, and the time taken to
remove scale significantly affects their
quality of life. Oral retinoids, the
current treatment for ARCI, efficiently
reduces scale formation but are also
rarely associated with side effects,
some serious (Rood et al., 2007).
Therefore, there is a need to develop
new treatments for ARCI.
Current research on alternate ARCI
treatments is focused on gene therapy
(Choate et al., 1996), or enzyme replace-
ment therapy, adding recombinant Tgm1
to the skin (Aufenvenne et al., 2012). A
greater understanding of the common
molecular mechanisms that lead to hyper-
keratosis would facilitate the discovery of
more directed therapies to reduce scaling
in ARCI. Therefore, we investigated com-
mon gene expression changes in two
different rat epidermal keratinocyte ARCI
models, to identify the common net-
works of differentially expressed genes
that are required for hyperkeratosis and,
within these molecular networks, to iden-
tify new ‘‘drug-able’’ targets for the reduc-
tion of hyperkeratosis.
Two separate Arachidonate 12-lipoxy-
genase (Alox12b) short hairpin RNA
(shRNA)–knockdown (kd) rat epider-
mal keratinocyte lines (Supplementary
Figure S1a and S1b online) were com-
pared with an existing Tgm1 shRNA–kd
line (O’Shaughnessy et al., 2010). Both
Tgm1- and Alox12b-kd organotypic
cultures were hyperkeratotic (Figure 1a).
Comparison of Tgm1-kd with Alox12b-kd
cultures revealed a common increase in
keratin 1 expression, but keratin 10 reduc-
tion was observed only in Tgm1-kd
cultures (Figure 1a and Supplementary
Figure S1c online), suggesting both com-
mon and distinct programs of altered gene
expression in the two models. Prin-
cipal component analysis confirmed that,
although phenotypically similar, overall
gene expression differences were diver-
gent (Figure 1b and Supplementary Figure
S2 online). Despite these differences, we
identified 155 genes that were commonly
upregulated and 78 genes that were com-
monly downregulated in both Tgm1- and
Alox12b-kd keratinocyte cultures (Supple-
mentary Table S1 online). We identified
upregulated genes related to the positive
regulation of apoptosis and downregulated
genes related to protein phosphorylation
(Supplementary Figure S3 online).
The only significant network of inter-
related genes was related to the genes
involved in the positive regulation of
apoptosis, and within this network we
identified the p53 ubiquitin ligase
Mdm2 as an attractive candidate gene
to target in order to reduce hyperker-
atosis, as mice overexpressing Mdm2
display a hyperkeratotic epidermis in a
p53-independent manner (Alkhalaf
et al., 1999). Mdm2 upregulation in
both Tgm1- and Alox12b-kd cultures
was confirmed by quantitative reverse
transcriptase in real-time PCR (Figure 1c
and d). In organotypic culture, cytoplasmicAccepted article preview online 4 September 2013; published online 17 October 2013
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